Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA

Autor: Dahl NV, Kaper RF, Strauss WE, Corvino FA, Zivkovic M

Publikováno v: ClinicoEconomics and Outcomes Research, Vol Volume 9, Pp 557-567 (2017)

Naomi V Dahl,1 Robert F Kaper,2 William E Strauss,1 Frank A Corvino,3 Marko Zivkovic3 1Medical Affairs, 2Medical & Scientific Affairs, AMAG Pharmaceuticals, Inc., Waltham, MA, 3Genesis Research, Hoboken, NJ, USA Objective: Ferumoxytol has demonstrate

Externí odkaz: https://doaj.org/article/beeb5cfd604b497f9affdb175f247d21

Third- and second-generation oral contraceptives are associated with similar risk estimates for venous thromboembolism

Autor: Norpoth T, H. Rekers, Kaper Rf

Publikováno v: The European journal of contraceptionreproductive health care : the official journal of the European Society of Contraception. 5(1)

A scientific discussion between 1995 and 1999 addressed the question whether second- and third-generation oral contraceptives (OCs) were associated with different risks of venous thromboembolism (VTE). Results from three epidemiological studies becam

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24b8d9d25f677e1910e356485584069a
https://pubmed.ncbi.nlm.nih.gov/10836658

Debate. Venous thromboembolism and the pill. Learning from the past: an essential need

Autor: Kaper, RF

Publikováno v: Human Reproduction; May 1998, Vol. 13 Issue: 5 p1120-1120, 1p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial.

Autor: Adkinson NF; Johns Hopkins University School of Medicine, Baltimore, Maryland., Strauss WE; AMAG Pharmaceuticals, Inc, Waltham, Massachusetts., Macdougall IC; Department of Renal Medicine, King's College Hospital, London, UK., Bernard KE; AMAG Pharmaceuticals, Inc, Waltham, Massachusetts., Auerbach M; Auerbach Hematology and Oncology, Baltimore, Maryland.; Georgetown University School of Medicine, DC, Washington., Kaper RF; AMAG Pharmaceuticals, Inc, Waltham, Massachusetts., Chertow GM; Stanford University, Stanford, California., Krop JS; AMAG Pharmaceuticals, Inc, Waltham, Massachusetts.

Publikováno v: American journal of hematology [Am J Hematol] 2018 May; Vol. 93 (5), pp. 683-690. Date of Electronic Publication: 2018 Feb 24.